Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus for treatment of pulmonary hypertension
2006-004224-37Phase 2Completed
- Sponsor
- Leipzig University
- Start
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of everolimus in pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH), sponsored by Leipzig University. Primary endpoints: 6-minute walk test distance improvement and Hemodynamic parameter improvement. Started Nov 2006; status: completed.
02
Drugs
everolimus
03
Conditions
pulmonary arterial hypertension (PAH)chronic thromboembolic pulmonary hypertension (CTEPH)
Beyond the preview
Go deeper on 2006-004224-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004224-37.